Medical Center "Verum"
Kyiv, Ukraine
Medical center in Kyiv
вул. Деміївська, 13, Holosiivskyi prospekt, 46Б, 3, Kyiv, 03039
About Medical Center "Verum"
"В клініці VERUM expert реалізовано принцип узгодженої медичної допомоги. Це означає, що: -мультидисциплінарна команда клініки VERUM expert об'єднала фахівців за більш ніж 50 напрямами: ви маєте доступ до лікарів всіх спеціалізацій в межах одного медичного закладу; -ви можете цілком покластися на професіоналізм та компетентність наших спеціалістів: кожен лікар VERUM expert має колосальний досвід і у своїй роботі спирається на світові протоколи діагностики та лікування; -всі необхідні діагностичні процедури пацієнт проходить на базі клініки VERUM expert: наша клініка має найсучасніше технічне устаткування експертного класу; -за необхідності лікарі VERUM expert збирають експертні консиліуми для вибору стратегії лікування."
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Kissei Pharmaceutical Co., Ltd.
2
Merck Sharp & Dohme LLC
2
Byondis B.V.
1
EirGenix, Inc.
1
OBI Pharma, Inc
1
Clinical Trials at Medical Center "Verum"
During the past decade, Medical Center "Verum" conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 4 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Efficacy and Safety Study of EG12014 Compared With Herceptin in Subjects With HER2 Positive Early Breast Cancer
2018-10-16
2022-01-20
Completed
807
Study of Adagloxad Simolenin (OBI-822)/OBI-821 in the Adjuvant Treatment of Patients With Globo H Positive TNBC
2018-12-05
2027-12-30
Recruiting
668
Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain.
2019-06-13
2022-04-01
Completed
486
SYD985 in Patients With HER2-expressing Recurrent, Advanced or Metastatic Endometrial Carcinoma
2020-05-28
2023-05-01
Active, not recruiting
60
Extension to Study on Efficacy and Safety of Linzagolix for the Treatment of Endometriosis-associated Pain (EDELWEISS 6)
2020-03-05
2023-03-01
Active, not recruiting
288
Study of Pembrolizumab With Concurrent Chemoradiation Therapy Followed by Pembrolizumab With or Without Olaparib in Stage III Non-Small Cell Lung Cancer (NSCLC) (MK-7339-012/KEYLYNK-012)
2020-07-06
2026-07-06
Recruiting
870
Placebo-controlled, Study of Concurrent Chemoradiation Therapy With Pembrolizumab Followed by Pembrolizumab and Olaparib in Newly Diagnosed Treatment-Naïve Limited-Stage Small Cell Lung Cancer (LS-SCLC) (MK 7339-013/KEYLYNK-013)
2020-12-08
2027-10-28
Recruiting
672
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Medical Center "Verum"" #1 sponsor was "Kissei Pharmaceutical Co., Ltd." with 2 trials, followed by "Merck Sharp & Dohme LLC" with 2 trials
sponsored, "Byondis B.V." with 1 trials sponsored, "EirGenix, Inc." with 1 trials sponsored and "OBI Pharma, Inc"
with 1 trials sponsored. Other sponsors include -5 different institutions and
companies that sponsored additional 5 trials in total.
Clinical Trials Conditions at Medical Center "Verum"
According to Clinical.Site data, the most researched conditions in "Medical Center "Verum"" are
"Endometriosis" (2 trials), "Breast Cancer" (1 trials), "Carcinoma, Non-Small-Cell Lung" (1 trials), "Endometrial Cancer" (1 trials) and "Lung Neoplasms" (1 trials). Many other conditions were trialed in "Medical Center "Verum"" in a lesser frequency.
Clinical Trials Intervention Types at Medical Center "Verum"
Most popular intervention types in "Medical Center "Verum"" are "Drug" (6 trials), "Biological" (3 trials), "Radiation" (2 trials), "Device" (1 trials) and "Other" (1 trials). Other intervention types were less common.
The name of intervention was led by "200 mg linzagolix tablet" (2 trials), "75 mg linzagolix tablet" (2 trials), "Add-back capsule (E2 1 mg / NETA 0.5 mg)" (2 trials), "Placebo capsule to match Add-back capsule" (2 trials) and "Placebo tablet to match 200 mg linzagolix tablet" (2 trials). Other intervention names were less common.
Clinical Trials Genders at Medical Center "Verum"
The vast majority of trials in "Medical Center "Verum"" are
4 trials for "Female" genders and 3 trials for "All" genders.
Clinical Trials Status at Medical Center "Verum"
Currently, there are NaN active trials in "Medical Center "Verum"".
undefined are not yet recruiting,
3 are recruiting,
2 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 2 completed trials in Medical Center "Verum",
undefined suspended trials,
and undefined terminated clinical trials to date.
Out of the total trials that were conducted in Medical Center "Verum", 0 "Phase 1"
clinical trials were conducted, 1 "Phase 2" clinical
trials and 6 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".